Literature DB >> 33783327

TRIM28 functions as a negative regulator of aggresome formation.

Jeeyoon Chang1,2, Hyun Jung Hwang1,2, Byungju Kim3, Yeon-Gil Choi2, Joori Park1,2, Yeonkyoung Park1,2, Ban Seok Lee1,2, Heedo Park4, Min Ji Yoon2, Jae-Sung Woo2, Chungho Kim2, Man-Seong Park4, Jong-Bong Lee3, Yoon Ki Kim1,2.   

Abstract

Selective recognition and elimination of misfolded polypeptides are crucial for protein homeostasis. When the ubiquitin-proteasome system is impaired, misfolded polypeptides tend to form small cytosolic aggregates and are transported to the aggresome and eventually eliminated by the autophagy pathway. Despite the importance of this process, the regulation of aggresome formation remains poorly understood. Here, we identify TRIM28/TIF1β/KAP1 (tripartite motif containing 28) as a negative regulator of aggresome formation. Direct interaction between TRIM28 and CTIF (cap binding complex dependent translation initiation factor) leads to inefficient aggresomal targeting of misfolded polypeptides. We also find that either treatment of cells with poly I:C or infection of the cells by influenza A viruses triggers the phosphorylation of TRIM28 at S473 in a way that depends on double-stranded RNA-activated protein kinase. The phosphorylation promotes association of TRIM28 with CTIF, inhibits aggresome formation, and consequently suppresses viral proliferation. Collectively, our data provide compelling evidence that TRIM28 is a negative regulator of aggresome formation.Abbreviations: BAG3: BCL2-associated athanogene 3; CTIF: CBC-dependent translation initiation factor; CED: CTIF-EEF1A1-DCTN1; DCTN1: dynactin subunit 1; EEF1A1: eukaryotic translation elongation factor 1 alpha 1; EIF2AK2: eukaryotic translation initiation factor 2 alpha kinase 2; HDAC6: histone deacetylase 6; IAV: influenza A virus; IP: immunoprecipitation; PLA: proximity ligation assay; polypeptidyl-puro: polypeptidyl-puromycin; qRT-PCR: quantitative reverse-transcription PCR; siRNA: small interfering RNA.

Entities:  

Keywords:  Aggrephagy; CTIF; DCTN1; EEF1A1; EIF2AK2; influenza A virus

Mesh:

Substances:

Year:  2021        PMID: 33783327      PMCID: PMC8726693          DOI: 10.1080/15548627.2021.1909835

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  63 in total

Review 1.  Aggresomes, inclusion bodies and protein aggregation.

Authors:  R R Kopito
Journal:  Trends Cell Biol       Date:  2000-12       Impact factor: 20.808

Review 2.  Protein misfolding, functional amyloid, and human disease.

Authors:  Fabrizio Chiti; Christopher M Dobson
Journal:  Annu Rev Biochem       Date:  2006       Impact factor: 23.643

3.  Tripartite motif proteins: an emerging antiviral protein family.

Authors:  Girish Patil; Shitao Li
Journal:  Future Virol       Date:  2019-01-21       Impact factor: 1.831

Review 4.  Cytoplasmic dynein in neurodegeneration.

Authors:  Judith Eschbach; Luc Dupuis
Journal:  Pharmacol Ther       Date:  2011-03-21       Impact factor: 12.310

5.  Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems.

Authors:  A García-Sastre; A Egorov; D Matassov; S Brandt; D E Levy; J E Durbin; P Palese; T Muster
Journal:  Virology       Date:  1998-12-20       Impact factor: 3.616

Review 6.  Inclusion body formation, macroautophagy, and the role of HDAC6 in neurodegeneration.

Authors:  Christiane Richter-Landsberg; Janina Leyk
Journal:  Acta Neuropathol       Date:  2013-08-03       Impact factor: 17.088

7.  TRIM28 regulates the nuclear accumulation and toxicity of both alpha-synuclein and tau.

Authors:  Maxime Wc Rousseaux; Maria de Haro; Cristian A Lasagna-Reeves; Antonia De Maio; Jeehye Park; Paymaan Jafar-Nejad; Ismael Al-Ramahi; Ajay Sharma; Lauren See; Nan Lu; Luis Vilanova-Velez; Tiemo J Klisch; Thomas F Westbrook; Juan C Troncoso; Juan Botas; Huda Y Zoghbi
Journal:  Elife       Date:  2016-10-25       Impact factor: 8.140

Review 8.  Strategies for Success. Viral Infections and Membraneless Organelles.

Authors:  Aracelly Gaete-Argel; Chantal L Márquez; Gonzalo P Barriga; Ricardo Soto-Rifo; Fernando Valiente-Echeverría
Journal:  Front Cell Infect Microbiol       Date:  2019-10-11       Impact factor: 5.293

9.  TRIM28 activates autophagy and promotes cell proliferation in glioblastoma.

Authors:  Yong Peng; Mingming Zhang; Zhongzhong Jiang; Yugang Jiang
Journal:  Onco Targets Ther       Date:  2019-01-03       Impact factor: 4.147

10.  Depleting Trim28 in adult mice is well tolerated and reduces levels of α-synuclein and tau.

Authors:  Maxime Wc Rousseaux; Jean-Pierre Revelli; Gabriel E Vázquez-Vélez; Ji-Yoen Kim; Evelyn Craigen; Kristyn Gonzales; Jaclyn Beckinghausen; Huda Y Zoghbi
Journal:  Elife       Date:  2018-06-04       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.